日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel Lung Cell-Penetrating Peptide Targets Alveolar Epithelial Type II Cells, Basal Cells, and Ionocytes

新型肺细胞穿透肽靶向肺泡上皮II型细胞、基底细胞和离子细胞

Jin Wen ,Gajalakshmi Singuru ,Jeffrey Stiltner ,Sanjay Mishra ,Kyle S Feldman ,Kayla McCandless ,Raymond Yurko ,Kazi Islam ,Ray Frizzell ,Hisato Yagi ,Jonathan M Brown ,Maliha Zahid

Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification

CT1812 的临床前和临床生物标志物研究:阿尔茨海默病治疗的新方法

Nicholas J Izzo, Carla M Yuede, Kelsie M LaBarbera, Colleen S Limegrover, Courtney Rehak, Raymond Yurko, Lora Waybright, Gary Look, Gilbert Rishton, Hank Safferstein, Mary E Hamby, Claire Williams, Kelsey Sadlek, Hannah M Edwards, Charles S Davis, Michael Grundman, Lon S Schneider, Steven T DeKosky,

Alzheimer's protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity

A673T 突变对阿尔茨海默病的保护作用可能是由较低的 Aβ 寡聚体结合亲和力引起的

Colleen S Limegrover, Harry LeVine 3rd, Nicholas J Izzo, Raymond Yurko, Kelsie Mozzoni, Courtney Rehak, Kelsey Sadlek, Hank Safferstein, Susan M Catalano

Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain-derived α-synuclein

Sigma-2 受体拮抗剂挽救帕金森病患者脑源性 α-突触核蛋白引起的神经元功能障碍

Colleen S Limegrover, Raymond Yurko, Nicholas J Izzo, Kelsie M LaBarbera, Courtney Rehak, Gary Look, Gilbert Rishton, Hank Safferstein, Susan M Catalano

Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery

构建成熟中枢神经系统模型:用于神经退行性疾病药物发现的预测筛选平台

Kelsie Mozzoni LaBarbera ,Colleen Limegrover ,Courtney Rehak ,Raymond Yurko ,Nicholas John Izzo ,Nicole Knezovich ,Emily Watto ,Lora Waybright ,Susan M Catalano

Cardiac Targeting Peptide, a Novel Cardiac Vector: Studies in Bio-Distribution, Imaging Application, and Mechanism of Transduction

心脏靶向肽——一种新型心脏载体:生物分布、成像应用和转导机制研究

Maliha Zahid, Kyle S Feldman, Gabriel Garcia-Borrero, Timothy N Feinstein, Nicholas Pogodzinski, Xinxiu Xu, Raymond Yurko, Michael Czachowski, Yijen L Wu, Neale S Mason, Cecilia W Lo

Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits

针对淀粉样蛋白 β 1-42 寡聚体的阿尔茨海默病治疗 I:Abeta 42 寡聚体与特定神经元受体的结合被改善认知缺陷的候选药物所取代

Nicholas J Izzo, Agnes Staniszewski, Lillian To, Mauro Fa, Andrew F Teich, Faisal Saeed, Harrison Wostein, Thomas Walko 3rd, Anisha Vaswani, Meghan Wardius, Zanobia Syed, Jessica Ravenscroft, Kelsie Mozzoni, Colleen Silky, Courtney Rehak, Raymond Yurko, Patricia Finn, Gary Look, Gilbert Rishton, Han